39 results on '"Edelstein, Howard"'
Search Results
2. Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir
3. Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection
4. Factors Associated With Retention Among Non–Perinatally HIV-Infected Youth in the HIV Research Network
5. Treatment of HIV in Outpatients with Schizophrenia, Schizoaffective Disorder and Bipolar Disease at Two County Clinics
6. Simplification to abacavir/lamivudine (ABC/3TC) + atazanavir (ATV) from tenofovir/emtricitabine (TDF/FTC) + ATV/ritonavir (r) maintains viral suppression and improves bone biomarkers: 48 weeks ASSURE study results.: 98E.
7. 106E. Prevalence of HIV-associated neurocognitive disorders (HAND) in virologically suppressed HIV-infected individuals in the ASSURE (EPZ113734) study versus non-HIV-infected control subjects.
8. Failure of treatment of tuberculous adenitis due to an unexpected drug interaction with rifabutin and efavirenz
9. The Prospective Payment System And Discharge Diagnoses For Coronary Heart Disease
10. Decision-making speed in HIV-1 infection: a preliminary report
11. Pulmonary Aspergillosis in the Acquired Immunodeficiency Syndrome
12. Primary nasal Kaposi Sarcoma in well-controlled HIV-positive patient with normal CD4 count associated with long-term nasal steroid use.
13. Discontinuity in Medicaid Coverage Among Young Adults with HIV.
14. Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials.
15. Long Survival without Zidovudine in the Acquired Immunodeficiency Syndrome (AIDS)
16. Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial.
17. DMZ paradox
18. Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.
19. Executive bashing
20. Randomized comparison trial of teicoplanin IV, teicoplanin IM, and cefazolin therapy for skin and...
21. Osteomyelitis of the jaw in patients infected with the human immunodeficiency virus.
22. Pneumococcal bacteremia as a marker for human immunodeficiency virus infection in patients without AIDS.
23. Performance of patients with early HIV-1 infection on the stroop task.
24. A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia.
25. Ceftibuten versus cefaclor for the treatment of bronchitis.
26. Perinephric abscess in pediatric patients: Report of six cases and review of the literature.
27. Perinephric Abscess in Renal Transplant Recipients: Report of Seven Cases and Review.
28. Letters and Corrections.
29. The Changing Landscape of Executive Retirement Plans.
30. Nonqualified Retirement Plans Take On Increased Importance In Estate Planning.
31. Internal Warts and Associated Anal Diseases Are Common in Patients Attending a County HIV Clinic.
32. Leptospirosis as a result of elk exposure.
33. Epstein-Barr virus causing encephalitis in an elderly woman.
34. Breast Abscess Due to Salmonella Serogroup B, Serotype Reading, in a Young Nonpuerperal Woman.
35. The Prospective Payment System and Discharge Diagnoses for Coronary Heart Disease.
36. Syphilis screening in a suburban community.
37. Multidermatomal Herpes Zoster in an AIDS Patient.
38. Power of Supplemental Pension Plans.
39. Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.